Stocktoria
NATURES SUNSHINE PRODUCTS INC NATR
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2009-06-25
NATURES SUNSHINE PRODUCTS INC financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $480.1M | $454.4M | $445.3M | $421.9M | $444.1M |
| Gross profit | $347.7M | $324.7M | $321.1M | $299.8M | $328.6M |
| R&D expense | $1.9M | $1.7M | $1.6M | $1.5M | $1.4M |
| SG&A expense | $178.4M | $164.0M | $167.1M | $153.1M | $154.1M |
| Operating income | $24.7M | $20.1M | $18.7M | $16.3M | $34.7M |
| Interest expense | — | — | $69,000 | $249,000 | $250,000 |
| Income tax | $9.4M | $10.5M | $3.8M | $14.7M | $1.6M |
| Net income | $19.5M | $7.7M | $15.1M | -$390,000 | — |
| EPS (diluted) | $1.06 | $0.40 | $0.77 | $-0.02 | $1.42 |
| Operating cash flow | $35.3M | $25.3M | $41.2M | $710,000 | $34.6M |
| Free cash flow | $28.8M | $14.3M | $30.7M | -$6.9M | $27.9M |
| Cash & equivalents | $93.9M | $84.7M | $82.4M | $60.0M | $86.2M |
| Inventory | $68.3M | $59.4M | $66.9M | $67.9M | $60.9M |
| Total assets | $261.1M | $240.9M | $249.8M | $229.8M | $258.9M |
| Total liabilities | $99.6M | $79.9M | $90.2M | $82.7M | $97.5M |
| Shareholders' equity | $161.6M | $161.0M | $159.5M | $147.0M | $161.4M |
Source: SEC EDGAR filings · CIK 0000275053 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.